中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 6
Jun.  2021
Turn off MathJax
Article Contents

Expression and significance of L1 cell adhesion molecule and transforming growth factor-β1 in pancreatic cancer tissue

DOI: 10.3969/j.issn.1001-5256.2021.06.035
  • Received Date: 2021-03-01
  • Accepted Date: 2021-03-15
  • Published Date: 2021-06-20
  •   Objective  To investigate the expression of L1 cell adhesion molecule (L1CAM) and transforming growth factor-β1 (TGFβ1) in pancreatic cancer tissue and their association with the prognosis of pancreatic cancer.  Methods  Histological specimens were collected from 125 patients with pancreatic cancer who underwent surgical resection in The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University Cancer Hospital, and Wuming Hospital of Guangxi Medical University from January 2015 to January 2018. Immunohistochemistry was used to measure the expression of L1CAM and TGFβ1 in all specimens, and the association of the expression of L1CAM and TGFβ1 with clinical indices, survival, and prognosis was analyzed. The t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups; the Cox proportional-hazards regression model was used to investigate the influencing factors for the survival of patients with pancreatic cancer; the Kaplan-Meier survival analysis was used to evaluate the survival of patients with different expression levels of L1CAM and TGFβ1.  Results  The high protein expression rate of L1CAM in pancreatic cancer tissue was significantly higher than that in adjacent tissue (75.20% vs 20.00%, χ2=76.352, P < 0.001). The high protein expression rate of TGFβ1 in pancreatic cancer tissue was significantly higher than that in adjacent tissue (81.60% vs 23.20%, χ2=85.461, P < 0.001). The protein expression of L1CAM was positively correlated with that of TGFβ1 in pancreatic cancer (r=0.492, P < 0.001). The protein expression of L1CAM and TGFβ1 were associated with tumor size, degree of tumor differentiation, TNM stage, lymph node metastasis, intravascular tumor thrombus, and perineural invasion (all P < 0.05). The patients with high protein expression of L1CAM or TGFβ1 had a significantly lower overall survival rate than those with low expression (χ2=54.661 and 39.597, both P < 0.001).  Conclusion  L1CAM and TGFβ1 proteins are highly expressed in pancreatic cancer tissue and may be associated with poor prognosis by promoting lymphatic metastasis and hematogenous metastasis. L1CAM and TGFβ1 proteins play an important role in the development, progression, and metastasis of pancreatic cancer.

     

  • loading
  • [1]
    CHU CL, TANG CH, XU LY, et al. Association between Toll-like receptor 4 and pancreatic cancer[J]. J Clin Hepatol, 2021, 37(2): 485-488. DOI: 10.3969/j.issn.1001-5256.2021.02.050.

    褚成龙, 唐朝辉, 徐露瑶, 等. Toll样受体4与胰腺癌的关系[J]. 临床肝胆病杂志, 2021, 37(2): 485-488. DOI: 10.3969/j.issn.1001-5256.2021.02.050.
    [2]
    CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
    [3]
    SAMATA B, TAKAICHI R, ISHⅡ Y, et al. L1CAM is a marker for enriching corticospinal motor neurons in the developing brain[J]. Front Cell Neurosci, 2020, 14: 31. DOI: 10.3389/fncel.2020.00031.
    [4]
    LINNEBERG C, TOFT C, KJAER-SORENSEN K, et al. L1cam-mediated developmental processes of the nervous system are differentially regulated by proteolytic processing[J]. Sci Rep, 2019, 9(1): 3716. DOI: 10.1038/s41598-019-39884-x.
    [5]
    SCHÄFER MK, ALTEVOGT P. L1CAM malfunction in the nervous system and human carcinomas[J]. Cell Mol Life Sci, 2010, 67(14): 2425-2437. DOI: 10.1007/s00018-010-0339-1.
    [6]
    ALTEVOGT P, DOBERSTEIN K, FOGEL M. L1CAM in human cancer[J]. Int J Cancer, 2016, 138(7): 1565-1576. DOI: 10.1002/ijc.29658.
    [7]
    ANGIOLINI F, CAVALLARO U. The pleiotropic role of L1CAM in tumor vasculature[J]. Int J Mol Sci, 2017, 18(2): 254. DOI: 10.3390/ijms18020254.
    [8]
    KIM KK, SHEPPARD D, CHAPMAN HA. TGF-β1 signaling and tissue fibrosis[J]. Cold Spring Harb Perspect Biol, 2018, 10(4): a022293. DOI: 10.1101/cshperspect.a022293.
    [9]
    TANG J, GIFFORD CC, SAMARAKOON R, et al. Deregulation of negative controls on TGF-β1 signaling in tumor progression[J]. Cancers (Basel), 2018, 10(6): 159. DOI: 10.3390/cancers10060159.
    [10]
    LIANG M, LIU XC, LIU T, et al. GLI-1 facilitates the EMT induced by TGF-β1 in gastric cancer[J]. Eur Rev Med Pharmacol Sci, 2018, 22(20): 6809-6815. DOI: 10.26355/eurrev_201810_16148.
    [11]
    YEN EY, MIAW SC, YU JS, et al. Exosomal TGF-β1 is correlated with lymphatic metastasis of gastric cancers[J]. Am J Cancer Res, 2017, 7(11): 2199-2208. http://pubmedcentralcanada.ca/pmcc/articles/PMC5714749/
    [12]
    MOON JR, OH SJ, LEE CK, et al. TGF-β1 protects colon tumor cells from apoptosis through XAF1 suppression[J]. Int J Oncol, 2019, 54(6): 2117-2126. DOI: 10.3892/ijo.2019.4776.
    [13]
    FEZZA M, MOUSSA M, AOUN R, et al. DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1[J]. PLoS One, 2019, 14(9): e0223252. DOI: 10.1371/journal.pone.0223252.
    [14]
    MARTELOSSI CEBINELLI GC, PAIVA TRUGILO K, BADARÓ GARCIA S, et al. TGF-β1 functional polymorphisms: A review[J]. Eur Cytokine Netw, 2016, 27(4): 81-89. DOI: 10.1684/ecn.2016.0382.
    [15]
    SAMATOV TR, WICKLEIN D, TONEVITSKY AG. L1CAM: Cell adhesion and more[J]. Prog Histochem Cytochem, 2016, 51(2): 25-32. DOI: 10.1016/j.proghi.2016.05.001.
    [16]
    PACE KR, DUTT R, GALILEO DS. Exosomal L1CAM stimulates glioblastoma cell motility, proliferation, and invasiveness[J]. Int J Mol Sci, 2019, 20(16): 3982. DOI: 10.3390/ijms20163982.
    [17]
    WACHOWIAK R, KRAUSE M, MAYER S, et al. Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors[J]. Medicine (Baltimore), 2018, 97(38): e12396. DOI: 10.1097/MD.0000000000012396.
    [18]
    ABDEL AZIM S, SPRUNG S, MUTZ-DEHBALAIE I, et al. L1CAM and HER2 expression in early endometrioid uterine cancer[J]. Int J Gynecol Pathol, 2017, 36(4): 356-363. DOI: 10.1097/PGP.0000000000000338.
    [19]
    GANESH K, BASNET H, KAYGUSUZ Y, et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer[J]. Nat Cancer, 2020, 1(1): 28-45. DOI: 10.1038/s43018-019-0006-x.
    [20]
    TAMPAKIS A, TAMPAKI EC, NONNI A, et al. L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease[J]. Acta Oncol, 2020, 59(1): 55-59. DOI: 10.1080/0284186X.2019.1667022.
    [21]
    YU H, ZHOU P, LI D, et al. L1CAM-positive expression is associated with poorer survival outcomes in resected non-small cell lung cancer patients[J]. Int J Clin Exp Pathol, 2019, 12(7): 2665-2671. http://www.ncbi.nlm.nih.gov/pubmed/31934096
    [22]
    ALTEVOGT P, BEN-ZE'EV A, GAVERT N, et al. Recent insights into the role of L1CAM in cancer initiation and progression[J]. Int J Cancer, 2020, 147(12): 3292-3296. DOI: 10.1002/ijc.33177.
    [23]
    GIORDANO M, CAVALLARO U. Different shades of L1CAM in the pathophysiology of cancer stem cells[J]. J Clin Med, 2020, 9(5): 1502. DOI: 10.3390/jcm9051502.
    [24]
    ABDEL AZIM S, SPRUNG S, MUTZ-DEHBALAIE I, et al. L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer[J]. Int J Gynecol Pathol, 2017, 36(4): 356-363. DOI: 10.1097/PGP.0000000000000338.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(2)

    Article Metrics

    Article views (934) PDF downloads(156) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return